Sincrolab offers an Artificial Intelligence digital prescription neuro medicine based on videogames delivered through mobile devices.
Sincrolab has raised $115K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2026.
Sincrolab's investors include Wayra, Clave Capital, Eoniq.fund, Growth Venture Partners.
Sincrolab is headquartered in Madrid, Spain.
Sincrolab offers an Artificial Intelligence digital prescription neuro medicine based on videogames delivered through mobile devices.
Sincrolab is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sincrolab — Funding & Investors." VCBacked, June 19, 2026, https://www.vcbacked.co/company/sincrolab. Accessed September 30, 2026.
VCBacked. (2026). Sincrolab — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/sincrolab
{{cite web |title=Sincrolab — Funding & Investors |url=https://www.vcbacked.co/company/sincrolab |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated